The experimental therapy tozorakimab from AstraZeneca was superior to a placebo at reducing the rate of moderate to severe exacerbations, or sudden episodes of symptom worsening, in adults with chronic obstructive pulmonary disease (COPD). That’s according to top-line, one-year data from two Phase 3 clinical trials —…

There are times in life when illness doesn’t just slow you down— it rearranges you. I didn’t see it happening at first. I thought I was simply tired or behind, in need of a weekend to catch up. But slowly, almost quietly, I began to lose the version of myself…

There are days when I realize my world has grown smaller without my permission. After illness, the boundaries of daily life contract almost imperceptibly. A trip that once felt routine — like driving to Tamarack, West Virginia, a place I’ve known for years — suddenly feels foreign, as…

When I was in my 20s, I was diagnosed with cancer over a phone call. What a way to practice medicine, but I felt something I didn’t expect: relief. Not because the diagnosis was easy — it wasn’t — but because the not‑knowing had been worse. The fear lived in…

For people with chronic obstructive pulmonary disease (COPD), characterized by cough and shortness of breath, Anoro Elipta (umeclidinium-vilanterol) may work better than other approved COPD medications at reducing the risk of disease flares. That’s according to a new federally funded study that used U.S. insurance data to compare…